Department of Psychology, Virginia Commonwealth University, 401 N. 11th Street, Richmond, VA, 23219, USA.
Friends Research Institute, Baltimore, MD, USA.
Harm Reduct J. 2021 Oct 13;18(1):103. doi: 10.1186/s12954-021-00553-w.
Recovery is a multidimensional process that includes health, quality of life, and citizenship. Recovery capital is a strengths-based concept representing the sum of an individual's resources that support recovery. This study (1) describes recovery capital, (2) examines the relationship between recovery capital and treatment duration, and (3) assesses differences by gender in recovery capital among people receiving medication for opioid use disorder (MOUD).
This is a secondary data analysis of a cross-sectional study, with survey and medical record review components, conducted with patients recruited from an office-based opioid treatment clinic between July and September 2019. Analyses included participants receiving MOUD with buprenorphine who completed the Brief Assessment of Recovery Capital (BARC-10; n = 130). Univariate analyses explored differences by gender. Multivariate linear regression assessed the relationship between BARC-10 total score and length of current treatment episode.
Participants were 54.6% women and 67.4% Black with mean age of 42.4 years (SD = 12.3). Mean length of current MOUD treatment was 396.1 days (SD = 245.9). Total BARC-10 scores were high, but participants perceived low community-level resources. Women scored higher than men within the health and purpose recovery dimensions. While length of treatment was not associated with BARC-10 score, experiencing recent discrimination was associated with a significantly lower BARC-10 score.
Recovery capital among individuals receiving MOUD was high suggesting that participants have resources to support recovery, but gender differences and prevalent discrimination highlight areas for improved intervention. More work is needed to investigate recovery capital as an alternative treatment outcome to abstinence in outpatient MOUD populations.
康复是一个多维度的过程，包括健康、生活质量和公民身份。康复资本是一个基于优势的概念，代表支持康复的个人资源总和。本研究（1）描述了康复资本，（2）考察了康复资本与治疗持续时间之间的关系，（3）评估了接受阿片类药物使用障碍（MOUD）药物治疗的人群中，性别对康复资本的差异。
这是一项横截面研究的二次数据分析，包括调查和病历审查部分，于 2019 年 7 月至 9 月期间在一个基于办公室的阿片类药物治疗诊所招募患者。分析包括接受丁丙诺啡 MOUD 且完成简短康复资本评估（BARC-10；n=130）的参与者。单变量分析探讨了性别差异。多元线性回归评估了 BARC-10 总分与当前治疗阶段长度之间的关系。
参与者中女性占 54.6%，黑人占 67.4%，平均年龄为 42.4 岁（SD=12.3）。当前 MOUD 治疗的平均持续时间为 396.1 天（SD=245.9）。BARC-10 总分较高，但参与者认为社区层面的资源较低。女性在健康和目的康复维度的得分高于男性。虽然治疗时间与 BARC-10 评分无关，但最近经历歧视与 BARC-10 评分显著降低相关。
接受 MOUD 治疗的个体的康复资本较高，表明参与者拥有支持康复的资源，但性别差异和普遍存在的歧视突出了需要改进干预的领域。需要更多的工作来研究康复资本作为门诊 MOUD 人群替代戒断的治疗结果。
